Carbidopa 25 MG / levodopa 100 MG Oral Tablet — RxCUI 197444
RxNorm drug concept · Semantic clinical drug
RxCUI 197444
Semantic clinical drug · SCD
● Current RxNorm concept 62 FDA products
155 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI197444
Official nameCarbidopa 25 MG / levodopa 100 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asCarbidopa 25 MG / L-DOPA 100 MG Oral Tablet; carbidopa (as carbidopa monohydrate) 25 MG / levodopa 100 MG Oral Tablet
FDA products mapped62
Package NDCs mapped155
Reported Medicaid activity (SDUD)118,925 prescriptions · 51 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Levodopa and Carbidopa: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It treats Parkinson’s disease and related parkinsonism, including parkinsonism after brain inflammation or carbon monoxide or manganese poisoning. Duopa is specifically for motor f...
- Follow your prescription exactly, since your doctor adjusts the dose slowly. Extended-release forms shouldn’t be chewed or crushed. Rytary and Crexont can be taken with or without...
- Nausea, dizziness, headache, vivid dreams, and uncontrolled movements called dyskinesia are common. Tell your doctor if these bother you, because a dose change may help.
- Be careful. Some people fall asleep suddenly with no warning, even after being on it a long time. If that happens, don’t drive or do risky activities, and tell your doctor.
🕸️ Concept Web — How Carbidopa 25 MG / levodopa 100 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Carbidopa 25 MG / levodopa 100 MG Oral Tablet
RxCUI 197444 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 3
The active substance itself — no strength, form, or brand attached yet.
-
Carbidopa
2019IN -
Levodopa
6375IN -
Carbidopa / levodopa
103990MIN
-
Carbidopa
-
Brand names 2
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Dhivy
2586027BN -
Sinemet
36572BN
-
Dhivy
-
Dose forms 12
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Carbidopa / levodopa Oral Tablet
371267SCDF -
Carbidopa / levodopa Oral Product
1155774SCDG -
Carbidopa / levodopa Pill
1155775SCDG -
Carbidopa / levodopa Oral Tablet [Dhivy]
2586031SBDF -
Carbidopa / levodopa Oral Tablet [Sinemet]
368414SBDF -
Dhivy Oral Product
2586029SBDG -
Dhivy Pill
2586030SBDG -
Sinemet Oral Product
1183182SBDG - +4 more in this family
-
Carbidopa / levodopa Oral Tablet
-
Clinical & branded drugs 6
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Carbidopa 25 MG
315568SCDC -
Levodopa 100 MG
316141SCDC -
Carbidopa 25 MG / levodopa 100 MG Oral Tablet [Dhivy]
2586032SBD -
Carbidopa 25 MG / levodopa 100 MG Oral Tablet [Sinemet]
724598SBD -
Carbidopa 25 MG / levodopa 100 MG [Dhivy]
2586028SBDC -
Carbidopa 25 MG / levodopa 100 MG [Sinemet]
724596SBDC
-
Carbidopa 25 MG
Showing up to 8 concepts per family — 19 of 23 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Carbidopa 25 MG
SCDC · 315568 -
Levodopa 100 MG
SCDC · 316141 -
Carbidopa / levodopa Oral Tablet
SCDF · 371267 -
Carbidopa / levodopa Oral Product
SCDG · 1155774 -
Carbidopa / levodopa Pill
SCDG · 1155775
Brand-Name Concepts
-
Carbidopa 25 MG / levodopa 100 MG Oral Tablet [Dhivy]
SBD · 2586032 -
Carbidopa 25 MG / levodopa 100 MG Oral Tablet [Sinemet]
SBD · 724598 -
Carbidopa 25 MG / levodopa 100 MG [Dhivy]
SBDC · 2586028 -
Carbidopa 25 MG / levodopa 100 MG [Sinemet]
SBDC · 724596 -
Carbidopa / levodopa Oral Tablet [Dhivy]
SBDF · 2586031 -
Carbidopa / levodopa Oral Tablet [Sinemet]
SBDF · 368414 -
Dhivy Oral Product
SBDG · 2586029 -
Dhivy Pill
SBDG · 2586030 -
Sinemet Oral Product
SBDG · 1183182 -
Sinemet Pill
SBDG · 1183183
📦 FDA Products & Package NDCs
62 products · 155 package NDCs
155 package NDCs map to RxCUI 197444 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00093-9701-01 | 100 TABLET in 1 BOTTLE (0093-9701-01) | Carbidopa and levodopa | Teva Pharmaceuticals USA, Inc. | 2022-01-18 |
| 00093-9701-05 | 500 TABLET in 1 BOTTLE (0093-9701-05) | Carbidopa and levodopa | Teva Pharmaceuticals USA, Inc. | 2022-06-14 |
| 00093-9702-01 | 100 TABLET in 1 BOTTLE (0093-9702-01) | Carbidopa and levodopa | Teva Pharmaceuticals USA, Inc. | 2022-02-25 |
| 00093-9702-05 | 500 TABLET in 1 BOTTLE (0093-9702-05) | Carbidopa and levodopa | Teva Pharmaceuticals USA, Inc. | 2022-03-24 |
| 00093-9702-10 | 1000 TABLET in 1 BOTTLE (0093-9702-10) | Carbidopa and levodopa | Teva Pharmaceuticals USA, Inc. | 2022-01-18 |
| 00093-9703-01 | 100 TABLET in 1 BOTTLE (0093-9703-01) | Carbidopa and levodopa | Teva Pharmaceuticals USA, Inc. | 2024-03-05 |
| 00093-9703-05 | 500 TABLET in 1 BOTTLE (0093-9703-05) | Carbidopa and levodopa | Teva Pharmaceuticals USA, Inc. | 2023-12-15 |
| 00093-9703-10 | 1000 TABLET in 1 BOTTLE (0093-9703-10) | Carbidopa and levodopa | Teva Pharmaceuticals USA, Inc. | 2024-02-08 |
| 00615-8516-39 | 30 TABLET in 1 BLISTER PACK (0615-8516-39) | Carbidopa and Levodopa | NCS HealthCare of KY, LLC dba Vangard Labs | 2024-11-27 |
| 00615-8536-05 | 15 TABLET in 1 BLISTER PACK (0615-8536-05) | Carbidopa and Levodopa | NCS HealthCare of KY, LLC dba Vangard Labs | 2024-09-10 |
| 00615-8536-28 | 28 TABLET in 1 BLISTER PACK (0615-8536-28) | Carbidopa and Levodopa | NCS HealthCare of KY, LLC dba Vangard Labs | 2024-09-10 |
| 00615-8536-39 | 30 TABLET in 1 BLISTER PACK (0615-8536-39) | Carbidopa and Levodopa | NCS HealthCare of KY, LLC dba Vangard Labs | 2024-09-10 |
| 00615-8555-39 | 30 TABLET in 1 BLISTER PACK (0615-8555-39) | Carbidopa and Levodopa | NCS HealthCare of KY, LLC dba Vangard Labs | 2024-10-24 |
| 00904-7501-61 | 100 BLISTER PACK in 1 CARTON (0904-7501-61) / 1 TABLET in 1... | Carbidopa and Levodopa | Major Pharmaceuticals | 2024-07-02 |
| 00904-7549-61 | 100 BLISTER PACK in 1 CARTON (0904-7549-61) / 1 TABLET in 1... | Carbidopa and Levodopa | Major Pharmaceuticals | 2025-04-28 |
| 31722-0381-01 | 100 TABLET in 1 BOTTLE (31722-381-01) | CARBIDOPA AND LEVODOPA | Camber Pharmaceuticals, Inc. | 2025-05-27 |
| 31722-0381-05 | 500 TABLET in 1 BOTTLE (31722-381-05) | CARBIDOPA AND LEVODOPA | Camber Pharmaceuticals, Inc. | 2025-05-27 |
| 31722-0382-01 | 100 TABLET in 1 BOTTLE (31722-382-01) | CARBIDOPA AND LEVODOPA | Camber Pharmaceuticals, Inc. | 2025-05-27 |
| 31722-0382-05 | 500 TABLET in 1 BOTTLE (31722-382-05) | CARBIDOPA AND LEVODOPA | Camber Pharmaceuticals, Inc. | 2025-05-27 |
| 31722-0382-10 | 1000 TABLET in 1 BOTTLE (31722-382-10) | CARBIDOPA AND LEVODOPA | Camber Pharmaceuticals, Inc. | 2025-05-27 |
| 31722-0383-01 | 100 TABLET in 1 BOTTLE (31722-383-01) | CARBIDOPA AND LEVODOPA | Camber Pharmaceuticals, Inc. | 2025-05-27 |
| 31722-0383-05 | 500 TABLET in 1 BOTTLE (31722-383-05) | CARBIDOPA AND LEVODOPA | Camber Pharmaceuticals, Inc. | 2025-05-27 |
| 31722-0383-10 | 1000 TABLET in 1 BOTTLE (31722-383-10) | CARBIDOPA AND LEVODOPA | Camber Pharmaceuticals, Inc. | 2025-05-27 |
| 42291-0472-01 | 100 TABLET in 1 BOTTLE (42291-472-01) | Carbidopa and levodopa | AvKARE | 2022-03-15 |
| 42291-0472-10 | 1000 TABLET in 1 BOTTLE (42291-472-10) | Carbidopa and levodopa | AvKARE | 2022-03-15 |
| 50090-5969-01 | 90 TABLET in 1 BOTTLE (50090-5969-1) | Carbidopa and Levodopa | A-S Medication Solutions | 2022-04-28 |
| 50090-5969-02 | 270 TABLET in 1 BOTTLE (50090-5969-2) | Carbidopa and Levodopa | A-S Medication Solutions | 2022-05-04 |
| 50090-5969-03 | 360 TABLET in 1 BOTTLE (50090-5969-3) | Carbidopa and Levodopa | A-S Medication Solutions | 2022-05-04 |
| 50090-6580-01 | 90 TABLET in 1 BOTTLE (50090-6580-1) | Carbidopa and Levodopa | A-S Medication Solutions | 2023-08-07 |
| 50090-6580-02 | 270 TABLET in 1 BOTTLE (50090-6580-2) | Carbidopa and Levodopa | A-S Medication Solutions | 2023-08-07 |
| 50090-6580-03 | 360 TABLET in 1 BOTTLE (50090-6580-3) | Carbidopa and Levodopa | A-S Medication Solutions | 2023-08-07 |
| 50090-6725-00 | 90 TABLET in 1 BOTTLE (50090-6725-0) | Carbidopa and Levodopa | A-S Medication Solutions | 2023-10-06 |
| 50090-6727-00 | 90 TABLET in 1 BOTTLE (50090-6727-0) | Carbidopa and levodopa | A-S Medication Solutions | 2023-10-06 |
| 50090-7498-01 | 90 TABLET in 1 BOTTLE (50090-7498-1) | Carbidopa and Levodopa | A-S Medication Solutions | 2025-01-21 |
| 50090-7498-02 | 270 TABLET in 1 BOTTLE (50090-7498-2) | Carbidopa and Levodopa | A-S Medication Solutions | 2025-01-21 |
| 50090-7498-03 | 360 TABLET in 1 BOTTLE (50090-7498-3) | Carbidopa and Levodopa | A-S Medication Solutions | 2025-01-21 |
| 50090-7499-00 | 90 TABLET in 1 BOTTLE (50090-7499-0) | Carbidopa and Levodopa | A-S Medication Solutions | 2025-01-21 |
| 50228-0457-01 | 100 TABLET in 1 BOTTLE (50228-457-01) | Carbidopa and Levodopa | ScieGen Pharmaceuticals Inc | 2021-05-07 |
| 50228-0457-05 | 500 TABLET in 1 BOTTLE (50228-457-05) | Carbidopa and Levodopa | ScieGen Pharmaceuticals Inc | 2021-05-07 |
| 50228-0457-10 | 1000 TABLET in 1 BOTTLE (50228-457-10) | Carbidopa and Levodopa | ScieGen Pharmaceuticals Inc | 2021-05-07 |
| 50228-0457-30 | 30 TABLET in 1 BOTTLE (50228-457-30) | Carbidopa and Levodopa | ScieGen Pharmaceuticals Inc | 2021-05-07 |
| 50228-0458-01 | 100 TABLET in 1 BOTTLE (50228-458-01) | Carbidopa and Levodopa | ScieGen Pharmaceuticals Inc | 2021-05-07 |
| 50228-0458-05 | 500 TABLET in 1 BOTTLE (50228-458-05) | Carbidopa and Levodopa | ScieGen Pharmaceuticals Inc | 2021-05-07 |
| 50228-0458-10 | 1000 TABLET in 1 BOTTLE (50228-458-10) | Carbidopa and Levodopa | ScieGen Pharmaceuticals Inc | 2021-05-07 |
| 50228-0458-30 | 30 TABLET in 1 BOTTLE (50228-458-30) | Carbidopa and Levodopa | ScieGen Pharmaceuticals Inc | 2021-05-07 |
| 50228-0459-01 | 100 TABLET in 1 BOTTLE (50228-459-01) | Carbidopa and Levodopa | ScieGen Pharmaceuticals Inc | 2021-05-07 |
| 50228-0459-05 | 500 TABLET in 1 BOTTLE (50228-459-05) | Carbidopa and Levodopa | ScieGen Pharmaceuticals Inc | 2021-05-07 |
| 50228-0459-10 | 1000 TABLET in 1 BOTTLE (50228-459-10) | Carbidopa and Levodopa | ScieGen Pharmaceuticals Inc | 2021-05-07 |
| 50228-0459-30 | 30 TABLET in 1 BOTTLE (50228-459-30) | Carbidopa and Levodopa | ScieGen Pharmaceuticals Inc | 2021-05-07 |
| 50268-0202-15 | 50 BLISTER PACK in 1 BOX (50268-202-15) / 1 TABLET in 1 BLI... | Carbidopa and Levodopa | AvPAK | 2026-06-23 |
Observed labelers:
Proficient Rx LP (27) ·
A-S Medication Solutions (12) ·
Advagen Pharma Ltd., (12) ·
ScieGen Pharmaceuticals Inc (12) ·
Sun Pharmaceutical Industries, Inc. (12) ·
Aurobindo Pharma Limited (8)
· +18 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.